IDH2 and astrocytoma (excluding glioblastoma): In adults, mutations in IDH1 or IDH2 confer a significant survival benefit in histologically lower-grade astrocytomas compared to their IDH-wildtype counterparts, and as such, is the most important prognostic factor in this group [4].